HomeStock SectorsEnergy StocksMiddle East Tensions Push...

Middle East Tensions Push Oil to 4-Month Highs Amid Supply Shock Risks

surged to near four-and-a-half-month highs as escalating Middle East tensions and President Trump’s ambiguous statements about potential US military involvement in the Israel-Iran conflict sent shockwaves through global energy markets.

WTI crude jumped 1.69% to $76.41 per barrel while climbed 1.29% to $77.69, reflecting growing concerns over supply disruptions in the world’s most critical oil-producing region. The uncertainty has prompted major investment banks to warn of significant price spikes, with Goldman Sachs estimating a $10 per barrel geopolitical premium and Barclays warning of potential prices exceeding $100 if the conflict escalates further.

Geopolitical Risk Premium Drives Market Volatility

Goldman Sachs analysts have calculated that geopolitical tensions could add approximately $10 per barrel to Brent crude prices from current mid-$70s levels, though the bank acknowledges oil could exceed $90 if Iranian supply faces disruption.

The investment bank pointed to the ongoing attacks by Yemeni Houthis on vessels transiting the Bab el-Mandeb Strait as a stark example of Middle Eastern oil export vulnerability. These supply route disruptions have already demonstrated how quickly regional conflicts can impact global energy security.

President Trump’s cryptic statements regarding potential US military action have further amplified market uncertainty. When pressed about joining Israel’s bombing campaign against Iranian nuclear facilities, Trump told reporters, “I may do it. I may not do it. I mean, nobody knows what I’m going to do.”

This deliberate ambiguity has created additional volatility as traders struggle to assess the likelihood of direct US involvement. The prospect of American military intervention represents a significant escalation that could trigger broader regional conflict and severe supply disruptions.

Goldman Sachs’ base-case scenario previously assumed Brent crude would average $60 per barrel in the final quarter without supply disruptions. However, this optimistic outlook appears increasingly unrealistic given the evolving geopolitical landscape and Trump’s apparent willingness to consider military action against Iran’s nuclear program.

Oil Supply Disruption Risks and Market Response

Barclays has issued even more dire warnings about potential price movements, suggesting crude could surge above $100 per barrel if Middle East hostilities intensify significantly.

The bank specifically noted that Brent could reach $85 per barrel if just half of Iran’s oil exports were disrupted. Iran currently exports over 2 million barrels of crude daily, with nearly all shipments destined for China, making any supply interruption globally significant.

The oil market’s response has been swift and decisive, with energy commodities leading broader commodity gains amid the geopolitical uncertainty. prices also climbed 0.53% to $4.010, while surged an impressive 4.19% to $2.639, reflecting broader energy sector strength. These price movements demonstrate how quickly geopolitical events can translate into tangible market impacts across the entire energy complex.

Despite the recent gains, oil prices retreated slightly as traders await clearer signals about US intentions and the ultimate scope of potential military action. Market participants remain highly sensitive to any developments that could either escalate or de-escalate the current crisis, with many adopting wait-and-see approaches while positioning for potential supply shocks.

***

Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions.

This article was originally published on The Tokenist. Check out The Tokenist’s free newsletter, Five Minute Finance, for weekly analysis of the biggest trends in finance and technology.

Most Popular

More from Author

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk...

Read Now

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year, I thought it would be a good idea to review the key areas of analysis for the stock market.Such a review includes my...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities, and equities. Central banks once again take the spotlight, with both the Reserve Bank of Australia (RBA) and the Reserve Bank of New...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...